Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Doebele currently holds 230,000 shares of Rain Therapeutics Inc. (RAIN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Doebele has been a net neutral trader of RAIN stock. They have purchased $0 and sold $0 worth of shares.
Robert Doebele's most recent insider trade was on Jan 23, 2026, when they sold 230,000 shares at $0.00 per share.
Robert Doebele serves as Executive at Rain Therapeutics Inc. (RAIN). They have executed 18 insider transactions totaling $0 over their tenure at the company.
Robert Doebele holds the position of Executive at Rain Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Robert Doebele has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Robert Doebele was on Jul 6, 2022, when they sold $15.4K worth of RAIN shares. This transaction involved 3,890 shares at $3.95 per share.
Robert Doebele currently owns 230,000 shares of Rain Therapeutics Inc. (RAIN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Doebele's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Doebele has 18 Form 4 filings on record as an insider at Rain Therapeutics Inc..
Set alerts for Robert Doebele and 40,000+ other insiders.